These results indicated that furin mutations might mostly increase expression in ACE2, followed by HSPA5 and TMPRSS2 in some cancers (Figure 8C-F), indicating furin mutations' possible regulatory roles for COVID-19 viral entry in cancers by increase of some receptor's expression. This evidence concerns the gene ACE2 and COVID-19.